http://www.iacfsme.org/BULLETINFALL2008/Fall08GoudsmitFatigueinMyalgicEnceph/tabid/292/Default.aspx
Illness |
Fatigue score (mean)
|
Reference |
|
Infectious mononucleosis |
19.9 |
Candy et al. 2003 30 |
|
CFS |
27.4 |
Cleare et al. 2005 26 |
|
CFS |
25.1 |
Cleare et al. 200127 |
|
CFS with co-morbid disorders |
26.2 |
Cleare et al. 200127 |
|
CFS (Two groups) |
22.5-23 |
Hobday et al. 2008 37 |
|
CFS |
24.43 |
Hyland et al. 2006 38 |
|
CFS |
19.0 |
Jason et al. 2000 39 |
|
CFS |
27.53 |
Jason et al. 1997 40 |
|
CFS |
25.1 |
Jerjes et al. 2007 41 |
|
CFS |
24.4 |
Jerjes et al. 2006 42 |
|
CFS (Two groups) |
23.79-24.18 |
Kerr et al. 2008 43 |
|
CFS |
22.2 |
McDermott et al. 2006 44 |
|
CFS |
24.2 |
Papadopoulos et al. 2008 45 |
|
Chronic fatigue (Three groups) |
23.1-25.3 |
Ridsdale et al. 2004 20 |
|
CFS |
28.24 |
Ridsdale et al. 2004 20 |
|
Chronic fatigue |
23.3 |
Ridsdale et al. 2001 32 |
|
CFS |
19.6 |
Ridsdale et al. 2001 32 |
|
CFS |
26.4 |
Skowera et al. 2004 28 |
|
Chronic fatigue |
18.49 |
Taylor et al. 2002 29 |
|
CFS (Two groups) |
17.0-17.9 |
Wallman et al. 2004 19 |
|
CFS (Two groups) |
24.26-25.58 |
Whitehead and Campion 2002 46 |
Illness |
Fatigue score (mean)
|
Reference |
|
CFS |
10 |
Caseras et al. 2008 34 |
|
CFS |
10.47 |
Caseras et al. 2006 35 |
|
CF/CFS (Two groups) |
6.89-7.04 |
Chalder et al. 1997 21 |
| CFS (Two groups) |
9.5-10.2 |
Deale et al. 1997 35 |
|
CF (Two groups) |
7.2-7.8 |
Cho et al. 2008 36 |
|
CFS (Two groups) |
9.5-10.2 |
Deale et al. 1997 31 |
|
CFS |
7.7 |
McDermott et al. 2006 44 |
|
CFS (Four groups) |
9.9-10.6 |
Powell et al. 2001 22 |
|
CFS |
9.0 |
Priebe et al. 2008.48 |
|
CFS |
10 |
White et al. 2004 47 |
34. Caseras X, Mataix-Cols D, Rimes KA, Giampietro V, Brammer M, Zelaya F, Chalder T & Godfrey E: The neural correlates of fatigue: An exploratory imaginal fatigue provocation study in chronic fatigue syndrome. Psychol Med 2008, 38(7): 941-951.
35. Caseras X, Mataix-Cols D, Giampietro V, Rimes KA, Brammer M, Zelaya F, Chalder T, Godfrey EL: Probing the working memory system in chronic fatigue syndrome: a functional magnetic resonance imaging study using the n-back task. Psychosom Med2006, 86:
DOI: 10.1097/01.psy.0000242770.50979.5f36. Cho HJ, Bhugra D, Wessely S: ‘Physical or psychological?’ – a comparative study of causal attribution for chronic fatigue in Brazilian and British primary care patients. Acta Psychiatr Scand, 2008, 118(1):34-41.
37. Hobday RA, Thomas S, O'Donovan A, Murphy M & Pinching AJ: Dietary intervention in chronic fatigue syndrome. J Hum Nutr Diet 2008, 21(2): 141-149.
38. Hyland ME, Sodergren SC, Lewith GT: Chronic fatigue syndrome. The role of positivity to illness in chronic fatigue syndrome patients. J Health Psychol 2006, 11:731-741.
39
Jason L, Taylor R, Kennedy CL: Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med 2000, 62:655-663.40 J
ason L, Ropacki MT, Santoro NB, Richman JA, Heatherly W, Taylor RR, Ferrari JR, Haney-Davis TM, Rademaker A, Dupuis J, Golding J, Plioplys AV, Plioplys, S: A screening instrument for chronic fatigue syndrome: reliability and validity. JCFS 1997, 3:39-59.41. Jerjes WK, Taylor NF, Wood PJ & Cleare AJ: Enhanced feedback sensitivity to prednisolone in chronic fatigue syndrome.Psychoneuroendocrinology2007, 32(2):192-198.
42. Jerjes WK, Taylor NF, Peters TJ, Wessely S, Cleare AJ: Urinary cortisol and cortisol metabolite excretion in chronic fatigue syndrome. Psychosom Med 2006, 68:578-582.
43. Kerr JR, Petty R, Burke B, Gough J, Fear D, Sinclair LI, Mattey DL, Richards SCM, Montgomery J, Baldwin DA, Kellam, P, Harrison TJ, Griffin GE, Main, J, Enlander D, Nutt DJ & Holgate ST: Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis 2008, 197(8): 1171-1184.
44.
McDermott C, Richards SCM, Thomas P, Montgomery J, Lewith G: A placebo-controlled, double-blind, randomized controlled trial of a natural killer cell stimulant (BioBran MGN-3) in chronic fatigue syndrome. QJM 2006, 99:461-468.45. Papadopoulos A, Ebrecht M, Roberts ADL, Poon L, Rohleder N & Cleare AJ: Glucocorticoid receptor mediated negative feedback in chronic fatigue syndrome using the low dose (0.5 mg) dexamethasone suppression test. J Affect Dis 2008, doi:10.1016/j.jad.2008.05.001.
46.
Whitehead L, Campion P: Can general practitioners manage chronic fatigue syndrome? A controlled trial. JCFS 2002, 10, 55-64.47. White PD, Nye KE, Pinching AJ, Yap TM, Power N, Vleck V, Bentley DJ, Thomas JM, Buckland M, Parkin JM: Immunological changes after both exercise and activity in chronic fatigue syndrome: a pilot study. JCFS 2004, 12: 51-66.
48. Priebe S, Fakhoury WK, Henningsen P. Functional incapacity and physical and psychological symptoms: How they interconnect in chronic fatigue syndrome. Psychopathology 2008, 41: 339-345.